WHO and Partners Strengthen Efforts Against Cervical Cancer
Advertisement
As world leaders arrive in Rio de Janeiro, Brazil, for the G20 Summit this weekend, the city's iconic Christ the Redeemer statue will be illuminated in the colour teal. The Brazilian advocates behind this effort are among many around the globe joining the World Health Organization (WHO) to mobilize efforts on a worldwide “Day of Action for Cervical Cancer Elimination.” Other countries are marking the day with campaigns to provide human papillomavirus (HPV) vaccination and screening, launching new health policies to align with the world’s first-ever effort to eliminate a cancer, and raising awareness in communities.
Four years ago to the day, 194 countries resolved to eliminate cervical cancer and WHO launched a global strategy. Since then, significant progress has been made. At least 144 countries have introduced the HPV vaccine, over 60 countries now include HPV testing in their cervical screening programmes and 83 countries include surgical-care services for cervical cancer in health-benefit packages.
“I thank all the health workers who are playing a critical role in this global effort,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “While we are making progress, we still face huge inequities, with women in low-income countries bearing most of the burden. Only with strong leadership and sustained investment can we achieve our shared goal of equitable access for communities most in need.”WHO,cervical cancer,G20,HPV, HPV vaccine
Marking this campaign for the fourth year, governments, partners and civil society are organizing various activities and commitments.
For example in India, Civil society groups in different states will host a series of activities that include awareness campaigns and trainings for health-care professionals.
WHO is launching new guidance on Target Product Profiles (TPPs) for HPV screening tests. This technical product outlines preferred standards for new HPV tests. The tests should be able to function even in remote areas in low- and middle-income country settings where disease burden is highest. The TPPs highlight the importance of tests that give women the option to collect their own samples for testing; and the value of tools that enable HPV testing in settings closer to where women receive care.
The new publication aims to support innovation in the HPV testing market, emphasizing high-performance, low-cost, and accessible solutions, particularly transformative in resource-limited settings.
Reference: https://www.who.int/news/item/17-11-2024-who-and-partners-rally-cervical-cancer-elimination-efforts
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.